why choose us

Clinical Trials Search

Showing 15,910 of 132,963 result(s)
Neuro-affective Response to Light in Depressed Adolescents and Young Adults

Status: Completed

Condition: Depression in Adolescence

Interventions: Blue light exposure

Date: 2023-01-25

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Status: Completed

Condition: Neoplasms

Interventions: VIP236 will be administered by IV infusion once every 3 weeks.

Date: 2023-01-25

Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant

Status: COMPLETED

Condition: Antipsychotic Induced Weight Gain

Interventions: Miricorilant 6 x 100 mg coated tablets

Date: 2023-01-25

A PHASED, PROSPECTIVE, MULTI-CENTER STUDY OF THE ELITA SYSTEM

Status: Completed

Condition: Refractive Error

Interventions: Each subject will receive a SILK lenticule removal procedure on one eye and a commercially available laser vision correction procedure on their fellow

Date: 2023-01-25

Exploratory Study of Switching From Combustible Cigarettes to the BIDI E-cigarette

Status: ACTIVE_NOT_RECRUITING

Condition: Smoking Cessation

Interventions: The BIDI will be dispensed, and subjects will be instructed to use the BIDI as often as they like during the 12 week period, and to switch completely

Date: 2023-01-25

3D-Printed Hand Orthosis Versus Thermoplastic Orthosis

Status: NOT_YET_RECRUITING

Condition: Thumb Osteoarthritis

Interventions: 3D printed splint (orthosis) help prevent the joint from shifting during pinch activities.
This reduces improper joint loading and helps reduce p

Date: 2023-01-25

Examining the Impact of an Online, Non-restrictive Diet Among Persons With Multiple Sclerosis

Status: COMPLETED

Condition: Multiple Sclerosis

Interventions: The intervention will involve 8 weeks of an online diet program.
Outcomes testing will occur at baseline and post-intervention (following 8 week

Date: 2023-01-25

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects

Status: Completed

Condition: Hepatic Impairment

Interventions: Camizestrant 75 mg tablets.
Experimental drug.

Date: 2023-01-25

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

Status: Completed

Condition: Pulmonary Disease, Chronic Obstructive

Interventions: Population-health management

Date: 2023-01-25